Global Artificial Lungs Market Report 2019, Competitive Landscape, Trends and Opportunities
The Artificial Lungs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Artificial Lungs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Artificial Lungs market.
Major players in the global Artificial Lungs market include:
Baxter International, Inc. (USA)
Fresenius Medical Care AG & Co. KGaA (Germany)
Abbott Diabetes Care, Inc. (USA)
Xenios AG (Germany)
Asahi Kasei Medical Co., Ltd. (Japan)
Terumo Heart, Inc. (USA)
Toray Medical Co., Ltd. (Japan)
HeartWare International, Inc. (USA)
Nipro Corporation (Japan)
Nikkiso Co., Ltd. (Japan)
SynCardia Systems, Inc. (USA)
F.Hoffmann-La Roche Ltd. (Switzerland)
Vital Therapies, Inc. (USA)
Jarvik Heart, Inc. (USA)
Medtronic, Inc. (USA)
Thoratec Corp. (USA)
On the basis of types, the Artificial Lungs market is primarily split into:
Type 1
Type 2
Type 3
On the basis of applications, the market covers:
Application 1
Application 2
Application 3
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Artificial Lungs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Artificial Lungs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Artificial Lungs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Artificial Lungs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Artificial Lungs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Artificial Lungs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Artificial Lungs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Artificial Lungs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Artificial Lungs market, including the global production and revenue forecast, regional forecast. It also foresees the Artificial Lungs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Artificial Lungs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Artificial Lungs market.
Major players in the global Artificial Lungs market include:
Baxter International, Inc. (USA)
Fresenius Medical Care AG & Co. KGaA (Germany)
Abbott Diabetes Care, Inc. (USA)
Xenios AG (Germany)
Asahi Kasei Medical Co., Ltd. (Japan)
Terumo Heart, Inc. (USA)
Toray Medical Co., Ltd. (Japan)
HeartWare International, Inc. (USA)
Nipro Corporation (Japan)
Nikkiso Co., Ltd. (Japan)
SynCardia Systems, Inc. (USA)
F.Hoffmann-La Roche Ltd. (Switzerland)
Vital Therapies, Inc. (USA)
Jarvik Heart, Inc. (USA)
Medtronic, Inc. (USA)
Thoratec Corp. (USA)
On the basis of types, the Artificial Lungs market is primarily split into:
Type 1
Type 2
Type 3
On the basis of applications, the market covers:
Application 1
Application 2
Application 3
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Artificial Lungs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Artificial Lungs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Artificial Lungs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Artificial Lungs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Artificial Lungs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Artificial Lungs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Artificial Lungs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Artificial Lungs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Artificial Lungs market, including the global production and revenue forecast, regional forecast. It also foresees the Artificial Lungs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 ARTIFICIAL LUNGS MARKET OVERVIEW
1.1 Product Overview and Scope of Artificial Lungs
1.2 Artificial Lungs Segment by Type
1.2.1 Global Artificial Lungs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Type
1.2.3 The Market Profile of Type
1.2.4 The Market Profile of Type
1.3 Global Artificial Lungs Segment by Application
1.3.1 Artificial Lungs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Application
1.3.3 The Market Profile of Application
1.3.4 The Market Profile of Application
1.4 Global Artificial Lungs Market by Region (2014-2026)
1.4.1 Global Artificial Lungs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3 Europe Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.2 UK Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.3 France Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Artificial Lungs Market Status and Prospect (2014-2026)
1.4.4 China Artificial Lungs Market Status and Prospect (2014-2026)
1.4.5 Japan Artificial Lungs Market Status and Prospect (2014-2026)
1.4.6 India Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Artificial Lungs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Artificial Lungs (2014-2026)
1.5.1 Global Artificial Lungs Revenue Status and Outlook (2014-2026)
1.5.2 Global Artificial Lungs Production Status and Outlook (2014-2026)
2 GLOBAL ARTIFICIAL LUNGS MARKET LANDSCAPE BY PLAYER
2.1 Global Artificial Lungs Production and Share by Player (2014-2019)
2.2 Global Artificial Lungs Revenue and Market Share by Player (2014-2019)
2.3 Global Artificial Lungs Average Price by Player (2014-2019)
2.4 Artificial Lungs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Artificial Lungs Market Competitive Situation and Trends
2.5.1 Artificial Lungs Market Concentration Rate
2.5.2 Artificial Lungs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Baxter International, Inc. (USA)
3.1.1 Baxter International, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Artificial Lungs Product Profiles, Application and Specification
3.1.3 Baxter International, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.1.4 Baxter International, Inc. (USA) Business Overview
3.2 Fresenius Medical Care AG & Co. KGaA (Germany)
3.2.1 Fresenius Medical Care AG & Co. KGaA (Germany) Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Artificial Lungs Product Profiles, Application and Specification
3.2.3 Fresenius Medical Care AG & Co. KGaA (Germany) Artificial Lungs Market Performance (2014-2019)
3.2.4 Fresenius Medical Care AG & Co. KGaA (Germany) Business Overview
3.3 Abbott Diabetes Care, Inc. (USA)
3.3.1 Abbott Diabetes Care, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Artificial Lungs Product Profiles, Application and Specification
3.3.3 Abbott Diabetes Care, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.3.4 Abbott Diabetes Care, Inc. (USA) Business Overview
3.4 Xenios AG (Germany)
3.4.1 Xenios AG (Germany) Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Artificial Lungs Product Profiles, Application and Specification
3.4.3 Xenios AG (Germany) Artificial Lungs Market Performance (2014-2019)
3.4.4 Xenios AG (Germany) Business Overview
3.5 Asahi Kasei Medical Co., Ltd. (Japan)
3.5.1 Asahi Kasei Medical Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Artificial Lungs Product Profiles, Application and Specification
3.5.3 Asahi Kasei Medical Co., Ltd. (Japan) Artificial Lungs Market Performance (2014-2019)
3.5.4 Asahi Kasei Medical Co., Ltd. (Japan) Business Overview
3.6 Terumo Heart, Inc. (USA)
3.6.1 Terumo Heart, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Artificial Lungs Product Profiles, Application and Specification
3.6.3 Terumo Heart, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.6.4 Terumo Heart, Inc. (USA) Business Overview
3.7 Toray Medical Co., Ltd. (Japan)
3.7.1 Toray Medical Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Artificial Lungs Product Profiles, Application and Specification
3.7.3 Toray Medical Co., Ltd. (Japan) Artificial Lungs Market Performance (2014-2019)
3.7.4 Toray Medical Co., Ltd. (Japan) Business Overview
3.8 HeartWare International, Inc. (USA)
3.8.1 HeartWare International, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Artificial Lungs Product Profiles, Application and Specification
3.8.3 HeartWare International, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.8.4 HeartWare International, Inc. (USA) Business Overview
3.9 Nipro Corporation (Japan)
3.9.1 Nipro Corporation (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Artificial Lungs Product Profiles, Application and Specification
3.9.3 Nipro Corporation (Japan) Artificial Lungs Market Performance (2014-2019)
3.9.4 Nipro Corporation (Japan) Business Overview
3.10 Nikkiso Co., Ltd. (Japan)
3.10.1 Nikkiso Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Artificial Lungs Product Profiles, Application and Specification
3.10.3 Nikkiso Co., Ltd. (Japan) Artificial Lungs Market Performance (2014-2019)
3.10.4 Nikkiso Co., Ltd. (Japan) Business Overview
3.11 SynCardia Systems, Inc. (USA)
3.11.1 SynCardia Systems, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Artificial Lungs Product Profiles, Application and Specification
3.11.3 SynCardia Systems, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.11.4 SynCardia Systems, Inc. (USA) Business Overview
3.12 F.Hoffmann-La Roche Ltd. (Switzerland)
3.12.1 F.Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Artificial Lungs Product Profiles, Application and Specification
3.12.3 F.Hoffmann-La Roche Ltd. (Switzerland) Artificial Lungs Market Performance (2014-2019)
3.12.4 F.Hoffmann-La Roche Ltd. (Switzerland) Business Overview
3.13 Vital Therapies, Inc. (USA)
3.13.1 Vital Therapies, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Artificial Lungs Product Profiles, Application and Specification
3.13.3 Vital Therapies, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.13.4 Vital Therapies, Inc. (USA) Business Overview
3.14 Jarvik Heart, Inc. (USA)
3.14.1 Jarvik Heart, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Artificial Lungs Product Profiles, Application and Specification
3.14.3 Jarvik Heart, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.14.4 Jarvik Heart, Inc. (USA) Business Overview
3.15 Medtronic, Inc. (USA)
3.15.1 Medtronic, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Artificial Lungs Product Profiles, Application and Specification
3.15.3 Medtronic, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.15.4 Medtronic, Inc. (USA) Business Overview
3.16 Thoratec Corp. (USA)
3.16.1 Thoratec Corp. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Artificial Lungs Product Profiles, Application and Specification
3.16.3 Thoratec Corp. (USA) Artificial Lungs Market Performance (2014-2019)
3.16.4 Thoratec Corp. (USA) Business Overview
4 GLOBAL ARTIFICIAL LUNGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Artificial Lungs Production and Market Share by Type (2014-2019)
4.2 Global Artificial Lungs Revenue and Market Share by Type (2014-2019)
4.3 Global Artificial Lungs Price by Type (2014-2019)
4.4 Global Artificial Lungs Production Growth Rate by Type (2014-2019)
4.4.1 Global Artificial Lungs Production Growth Rate of Type 1 (2014-2019)
4.4.2 Global Artificial Lungs Production Growth Rate of Type 2 (2014-2019)
4.4.3 Global Artificial Lungs Production Growth Rate of Type 3 (2014-2019)
5 GLOBAL ARTIFICIAL LUNGS MARKET ANALYSIS BY APPLICATION
5.1 Global Artificial Lungs Consumption and Market Share by Application (2014-2019)
5.2 Global Artificial Lungs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Artificial Lungs Consumption Growth Rate of Application 1 (2014-2019)
5.2.2 Global Artificial Lungs Consumption Growth Rate of Application 2 (2014-2019)
5.2.3 Global Artificial Lungs Consumption Growth Rate of Application 3 (2014-2019)
6 GLOBAL ARTIFICIAL LUNGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Artificial Lungs Consumption by Region (2014-2019)
6.2 United States Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.4 China Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.6 India Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Artificial Lungs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL ARTIFICIAL LUNGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Artificial Lungs Production and Market Share by Region (2014-2019)
7.2 Global Artificial Lungs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
8 ARTIFICIAL LUNGS MANUFACTURING ANALYSIS
8.1 Artificial Lungs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Artificial Lungs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Artificial Lungs Industrial Chain Analysis
9.2 Raw Materials Sources of Artificial Lungs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Artificial Lungs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL ARTIFICIAL LUNGS MARKET FORECAST (2019-2026)
11.1 Global Artificial Lungs Production, Revenue Forecast (2019-2026)
11.1.1 Global Artificial Lungs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Artificial Lungs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Artificial Lungs Price and Trend Forecast (2019-2026)
11.2 Global Artificial Lungs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Artificial Lungs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Artificial Lungs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Artificial Lungs
1.2 Artificial Lungs Segment by Type
1.2.1 Global Artificial Lungs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Type
1.2.3 The Market Profile of Type
1.2.4 The Market Profile of Type
1.3 Global Artificial Lungs Segment by Application
1.3.1 Artificial Lungs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Application
1.3.3 The Market Profile of Application
1.3.4 The Market Profile of Application
1.4 Global Artificial Lungs Market by Region (2014-2026)
1.4.1 Global Artificial Lungs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3 Europe Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.2 UK Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.3 France Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Artificial Lungs Market Status and Prospect (2014-2026)
1.4.4 China Artificial Lungs Market Status and Prospect (2014-2026)
1.4.5 Japan Artificial Lungs Market Status and Prospect (2014-2026)
1.4.6 India Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Artificial Lungs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Artificial Lungs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Artificial Lungs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Artificial Lungs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Artificial Lungs (2014-2026)
1.5.1 Global Artificial Lungs Revenue Status and Outlook (2014-2026)
1.5.2 Global Artificial Lungs Production Status and Outlook (2014-2026)
2 GLOBAL ARTIFICIAL LUNGS MARKET LANDSCAPE BY PLAYER
2.1 Global Artificial Lungs Production and Share by Player (2014-2019)
2.2 Global Artificial Lungs Revenue and Market Share by Player (2014-2019)
2.3 Global Artificial Lungs Average Price by Player (2014-2019)
2.4 Artificial Lungs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Artificial Lungs Market Competitive Situation and Trends
2.5.1 Artificial Lungs Market Concentration Rate
2.5.2 Artificial Lungs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Baxter International, Inc. (USA)
3.1.1 Baxter International, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Artificial Lungs Product Profiles, Application and Specification
3.1.3 Baxter International, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.1.4 Baxter International, Inc. (USA) Business Overview
3.2 Fresenius Medical Care AG & Co. KGaA (Germany)
3.2.1 Fresenius Medical Care AG & Co. KGaA (Germany) Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Artificial Lungs Product Profiles, Application and Specification
3.2.3 Fresenius Medical Care AG & Co. KGaA (Germany) Artificial Lungs Market Performance (2014-2019)
3.2.4 Fresenius Medical Care AG & Co. KGaA (Germany) Business Overview
3.3 Abbott Diabetes Care, Inc. (USA)
3.3.1 Abbott Diabetes Care, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Artificial Lungs Product Profiles, Application and Specification
3.3.3 Abbott Diabetes Care, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.3.4 Abbott Diabetes Care, Inc. (USA) Business Overview
3.4 Xenios AG (Germany)
3.4.1 Xenios AG (Germany) Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Artificial Lungs Product Profiles, Application and Specification
3.4.3 Xenios AG (Germany) Artificial Lungs Market Performance (2014-2019)
3.4.4 Xenios AG (Germany) Business Overview
3.5 Asahi Kasei Medical Co., Ltd. (Japan)
3.5.1 Asahi Kasei Medical Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Artificial Lungs Product Profiles, Application and Specification
3.5.3 Asahi Kasei Medical Co., Ltd. (Japan) Artificial Lungs Market Performance (2014-2019)
3.5.4 Asahi Kasei Medical Co., Ltd. (Japan) Business Overview
3.6 Terumo Heart, Inc. (USA)
3.6.1 Terumo Heart, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Artificial Lungs Product Profiles, Application and Specification
3.6.3 Terumo Heart, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.6.4 Terumo Heart, Inc. (USA) Business Overview
3.7 Toray Medical Co., Ltd. (Japan)
3.7.1 Toray Medical Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Artificial Lungs Product Profiles, Application and Specification
3.7.3 Toray Medical Co., Ltd. (Japan) Artificial Lungs Market Performance (2014-2019)
3.7.4 Toray Medical Co., Ltd. (Japan) Business Overview
3.8 HeartWare International, Inc. (USA)
3.8.1 HeartWare International, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Artificial Lungs Product Profiles, Application and Specification
3.8.3 HeartWare International, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.8.4 HeartWare International, Inc. (USA) Business Overview
3.9 Nipro Corporation (Japan)
3.9.1 Nipro Corporation (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Artificial Lungs Product Profiles, Application and Specification
3.9.3 Nipro Corporation (Japan) Artificial Lungs Market Performance (2014-2019)
3.9.4 Nipro Corporation (Japan) Business Overview
3.10 Nikkiso Co., Ltd. (Japan)
3.10.1 Nikkiso Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Artificial Lungs Product Profiles, Application and Specification
3.10.3 Nikkiso Co., Ltd. (Japan) Artificial Lungs Market Performance (2014-2019)
3.10.4 Nikkiso Co., Ltd. (Japan) Business Overview
3.11 SynCardia Systems, Inc. (USA)
3.11.1 SynCardia Systems, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Artificial Lungs Product Profiles, Application and Specification
3.11.3 SynCardia Systems, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.11.4 SynCardia Systems, Inc. (USA) Business Overview
3.12 F.Hoffmann-La Roche Ltd. (Switzerland)
3.12.1 F.Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Artificial Lungs Product Profiles, Application and Specification
3.12.3 F.Hoffmann-La Roche Ltd. (Switzerland) Artificial Lungs Market Performance (2014-2019)
3.12.4 F.Hoffmann-La Roche Ltd. (Switzerland) Business Overview
3.13 Vital Therapies, Inc. (USA)
3.13.1 Vital Therapies, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Artificial Lungs Product Profiles, Application and Specification
3.13.3 Vital Therapies, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.13.4 Vital Therapies, Inc. (USA) Business Overview
3.14 Jarvik Heart, Inc. (USA)
3.14.1 Jarvik Heart, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Artificial Lungs Product Profiles, Application and Specification
3.14.3 Jarvik Heart, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.14.4 Jarvik Heart, Inc. (USA) Business Overview
3.15 Medtronic, Inc. (USA)
3.15.1 Medtronic, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Artificial Lungs Product Profiles, Application and Specification
3.15.3 Medtronic, Inc. (USA) Artificial Lungs Market Performance (2014-2019)
3.15.4 Medtronic, Inc. (USA) Business Overview
3.16 Thoratec Corp. (USA)
3.16.1 Thoratec Corp. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Artificial Lungs Product Profiles, Application and Specification
3.16.3 Thoratec Corp. (USA) Artificial Lungs Market Performance (2014-2019)
3.16.4 Thoratec Corp. (USA) Business Overview
4 GLOBAL ARTIFICIAL LUNGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Artificial Lungs Production and Market Share by Type (2014-2019)
4.2 Global Artificial Lungs Revenue and Market Share by Type (2014-2019)
4.3 Global Artificial Lungs Price by Type (2014-2019)
4.4 Global Artificial Lungs Production Growth Rate by Type (2014-2019)
4.4.1 Global Artificial Lungs Production Growth Rate of Type 1 (2014-2019)
4.4.2 Global Artificial Lungs Production Growth Rate of Type 2 (2014-2019)
4.4.3 Global Artificial Lungs Production Growth Rate of Type 3 (2014-2019)
5 GLOBAL ARTIFICIAL LUNGS MARKET ANALYSIS BY APPLICATION
5.1 Global Artificial Lungs Consumption and Market Share by Application (2014-2019)
5.2 Global Artificial Lungs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Artificial Lungs Consumption Growth Rate of Application 1 (2014-2019)
5.2.2 Global Artificial Lungs Consumption Growth Rate of Application 2 (2014-2019)
5.2.3 Global Artificial Lungs Consumption Growth Rate of Application 3 (2014-2019)
6 GLOBAL ARTIFICIAL LUNGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Artificial Lungs Consumption by Region (2014-2019)
6.2 United States Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.4 China Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.6 India Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Artificial Lungs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Artificial Lungs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL ARTIFICIAL LUNGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Artificial Lungs Production and Market Share by Region (2014-2019)
7.2 Global Artificial Lungs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Artificial Lungs Production, Revenue, Price and Gross Margin (2014-2019)
8 ARTIFICIAL LUNGS MANUFACTURING ANALYSIS
8.1 Artificial Lungs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Artificial Lungs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Artificial Lungs Industrial Chain Analysis
9.2 Raw Materials Sources of Artificial Lungs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Artificial Lungs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL ARTIFICIAL LUNGS MARKET FORECAST (2019-2026)
11.1 Global Artificial Lungs Production, Revenue Forecast (2019-2026)
11.1.1 Global Artificial Lungs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Artificial Lungs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Artificial Lungs Price and Trend Forecast (2019-2026)
11.2 Global Artificial Lungs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Artificial Lungs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Artificial Lungs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Artificial Lungs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
